|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02196 FOSUN PHARMA
Nominal 
15.960 -0.120 (-0.746%) Ranking Overview
Ranking based on 4 research report(s)
Average Ranking 2.50
|
Strong Buy (1)
0
|
Buy (2)
2
|
Hold (3)
2
|
Sell (4)
0
|
Strong Sell (5)
0
|
Previous Financial Performance
| Financial Year | 12/2023 | EPS | 90.00 RMB (cts) | |
| Net Profit | 2,398.61 RMB (MIL) | DPS | 27.00 RMB (cts) |
Consolidation Estimation
| Financial Year | Profit / (Loss) (RMB (MIL)) |
EPS/ ((LPS)(RMB (cts)) |
DPS (RMB (cts)) |
Net Asset Value per Share (RMB) |
Highest (RMB (MIL)) |
Lowest (RMB (MIL)) |
| 2024 | 2,720.50 | 103.50 | 30.00 | -- | 3,190.00 | 2,600.08 |
| 2025 | 3,179.11 | 119.00 | 39.30 | -- | 4,074.00 | 2,973.00 |
| 2026 | 3,801.72 | 142.50 | 40.00 | -- | 4,986.00 | 3,236.00 |
Profit Estimation
| Profit Estimation | Profit / (Loss) (RMB (MIL)) |
EPS*/ (LPS) (RMB (cts)) |
DPS * (RMB (cts)) |
Broker | Ranking | Target Price* (HKD) |
Update Date | |
| 2024 | 3,190.00 | 119.00 | -- | CITIC SEC | Buy | 19.00 | 10/09/2024 | |
| 2024 | 2,814.00 | 105.00 | 30.00 | CLSA | OutPerform | 15.80 | 23/01/2025 | |
| 2024 | 2,600.08 | 97.00 | 30.70 | MORGAN STANLEY | Equal-weight | 14.20 | 17/01/2025 | |
| 2024 | 2,627.00 | 102.00 | 30.00 | HSBC | Hold | 13.00 | 27/01/2025 | |
| 2025 | 4,074.00 | 152.00 | -- | CITIC SEC | -- | -- | 10/09/2024 | |
| 2025 | 3,264.00 | 122.00 | 40.00 | CLSA | -- | -- | 23/01/2025 | |
| 2025 | 3,094.22 | 116.00 | 39.30 | MORGAN STANLEY | -- | -- | 17/01/2025 | |
| 2025 | 2,973.00 | 116.00 | 33.00 | HSBC | -- | -- | 27/01/2025 | |
| 2026 | 4,986.00 | 187.00 | -- | CITIC SEC | -- | -- | 10/09/2024 | |
| 2026 | 3,757.00 | 141.00 | 40.00 | CLSA | -- | -- | 23/01/2025 | |
| 2026 | 3,846.43 | 144.00 | 49.12 | MORGAN STANLEY | -- | -- | 17/01/2025 | |
| 2026 | 3,236.00 | 126.00 | 36.00 | HSBC | -- | -- | 27/01/2025 | |
| Remarks: | Average rating ranges from 1 to 5. The lower the figure, the higher the rating and the vice versa. |
| *EPS, DPS and Estimated Price would be adjusted upon Consolidation, Split and Bonus Issue | |
| Real time quote last updated: 27/02/2025 11:04 | |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 1,224,799 |
| %Change | -31.332% |
| EPS / (LPS) | RMB 0.460 |
| NBV Per Share (¥) | RMB 17.561 |